Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim D Holmes

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Seminars in Immunology|June 30, 2016
Natural killer cell memory in contextTim D Holmes, Yenan T Bryceson
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2010
A human NK cell activation/inhibition threshold allows small changes in the target cell surface phenotype to dramatically alter susceptibility to NK cellsTim D Holmes, Yasser M El-Sherbiny, Adam Davison, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHTTim D Holmes, Erica B Wilson, Emma V I Black, et al.
Frontiers in Immunology|September 25, 2023
Herring roe oil in treatment of psoriasis - influence on immune cells and cytokine networkAleksandra Petrovic, Ingvild Bueide, Kåre Steinar Tveit, et al.
Nature Immunology|September 19, 2018
NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell developmentVedrana Jelenčić, Marko Šestan, Inga Kavazović, et al.
Nature Immunology|November 20, 2024
Author Correction: NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell developmentVedrana Jelenčić, Marko Šestan, Inga Kavazović, et al.
Immunology|February 14, 2022
Oncolytic virus treatment differentially affects the CD56<sup>dim</sup> and CD56<sup>bright</sup> NK cell subsets in vivo and regulates a spectrum of human NK cell activityMichelle Wantoch, Erica B Wilson, Alastair P Droop, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2009
Proteolytic activation of the cytotoxic phenotype during human NK cell developmentJosephine L Meade, Erica B Wilson, Tim D Holmes, et al.
Cancer Research|September 19, 2007
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cellsYasser M El-Sherbiny, Josephine L Meade, Tim D Holmes, et al.
Immunity|March 19, 2015
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector functionHeinrich Schlums, Frank Cichocki, Bianca Tesi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Seminars in Immunology|June 30, 2016
Natural killer cell memory in contextTim D Holmes, Yenan T Bryceson
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2010
A human NK cell activation/inhibition threshold allows small changes in the target cell surface phenotype to dramatically alter susceptibility to NK cellsTim D Holmes, Yasser M El-Sherbiny, Adam Davison, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHTTim D Holmes, Erica B Wilson, Emma V I Black, et al.
Frontiers in Immunology|September 25, 2023
Herring roe oil in treatment of psoriasis - influence on immune cells and cytokine networkAleksandra Petrovic, Ingvild Bueide, Kåre Steinar Tveit, et al.
Nature Immunology|September 19, 2018
NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell developmentVedrana Jelenčić, Marko Šestan, Inga Kavazović, et al.
Nature Immunology|November 20, 2024
Author Correction: NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell developmentVedrana Jelenčić, Marko Šestan, Inga Kavazović, et al.
Immunology|February 14, 2022
Oncolytic virus treatment differentially affects the CD56<sup>dim</sup> and CD56<sup>bright</sup> NK cell subsets in vivo and regulates a spectrum of human NK cell activityMichelle Wantoch, Erica B Wilson, Alastair P Droop, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2009
Proteolytic activation of the cytotoxic phenotype during human NK cell developmentJosephine L Meade, Erica B Wilson, Tim D Holmes, et al.
Cancer Research|September 19, 2007
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cellsYasser M El-Sherbiny, Josephine L Meade, Tim D Holmes, et al.
Immunity|March 19, 2015
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector functionHeinrich Schlums, Frank Cichocki, Bianca Tesi, et al.
Pageof 2